0,935  0,005  Apoptosis agonist
0,918  0,005  Antiinflammatory
0,896  0,006  Transcription factor NF kappa B inhibitor
0,863  0,005  Antineoplastic (breast cancer)
0,858  0,004  Chemopreventive
0,860  0,005  Antineoplastic (lung cancer)
0,854  0,004  Antineoplastic (melanoma)
0,853  0,005  Caspase 9 stimulant
0,825  0,002  Antineoplastic (endocrine cancer)
0,810  0,005  Antineoplastic (ovarian cancer)
0,794  0,008  Antineoplastic (colorectal cancer)
0,786  0,004  AR expression inhibitor
0,789  0,007  Antineoplastic (colon cancer)
0,776  0,004  Nitric oxide antagonist
0,769  0,008  Antileukemic
0,742  0,003  UGT1A4 substrate
0,742  0,005  Hepatic disorders treatment
0,740  0,007  Prostate cancer treatment
0,730  0,005  NOS2 expression inhibitor
0,722  0,005  Antineoplastic (cervical cancer)
0,713  0,005  Caspase 3 stimulant
0,707  0,005  Antineoplastic (pancreatic cancer)
0,711  0,009  Chemoprotective
0,699  0,004  Antiviral (HIV)
0,703  0,014  TNF expression inhibitor
0,683  0,003  Phospholipase C inhibitor
0,670  0,004  Hepatoprotectant
0,648  0,020  Cyclophilin D inhibitor
0,648  0,020  Antidiabetic
0,620  0,008  Apoptosis antagonist
0,615  0,005  Hair growth stimulant
0,601  0,004  Insulin secretagoues
0,609  0,013  Bone diseases treatment
0,587  0,004  Antiviral (Influenza A)
0,586  0,012  Antiosteoporotic
0,588  0,020  Cholesterol antagonist
0,574  0,008  Angiogenesis stimulant
0,568  0,005  ICAM1 expression inhibitor
0,562  0,003  Interferon gamma antagonist
0,561  0,004  Antiviral (Influenza)
0,561  0,012  Antineoplastic (multiple myeloma)
0,552  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,554  0,008  Antihelmintic
0,557  0,011  Antiprotozoal (Leishmania)
0,545  0,002  UGT2B9 substrate
0,539  0,003  Abortion inducer
0,552  0,020  Carcinogenic
0,551  0,019  Antipruritic, allergic
0,534  0,008  Antihypertriglyceridemic
0,548  0,023  Immunostimulant
0,539  0,016  Antioxidant
0,541  0,019  Cytotoxic
0,534  0,014  Antiparasitic
0,524  0,011  UDP-glucuronosyltransferase substrate
0,527  0,015  Antineoplastic (glioma)
0,510  0,005  Protein-tyrosine phosphatase inhibitor
0,520  0,018  Proliferative diseases treatment
0,520  0,028  Immunosuppressant
0,509  0,018  Antineoplastic (brain cancer)
0,499  0,009  Antineoplastic (carcinoma)
0,494  0,005  UGT2B7 substrate
0,500  0,015  Hypoxia-inducible factor 1 alpha inhibitor
0,501  0,017  Metabolic disease treatment
0,490  0,010  Antineoplastic (lymphocytic leukemia)
0,491  0,010  UGT1A1 substrate
0,496  0,023  Sensitization
0,471  0,004  Insulin sensitizer
0,478  0,014  UGT2B4 substrate
0,467  0,007  Platelet adhesion inhibitor
0,475  0,019  Antidiabetic (type 2)
0,470  0,014  Vascular (periferal) disease treatment
0,459  0,004  AMP-activated protein kinase stimulant
0,471  0,018  Antineoplastic (glioblastoma multiforme)
0,473  0,024  NOS3 expression inhibitor
0,466  0,019  Hypoglycemic
0,447  0,009  Contraceptive
0,439  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,440  0,009  Sodium/bile acid cotransporter inhibitor
0,452  0,020  Antipyretic
0,461  0,032  Antihypercholesterolemic
0,435  0,009  Antiviral (Hepatitis)
0,429  0,005  Antiviral (Hepatitis B)
0,431  0,012  Antiviral (Herpes)
0,421  0,003  Phosphorylase inhibitor
0,467  0,051  Antibacterial
0,424  0,009  Antiacne
0,424  0,009  Prostate disorders treatment
0,440  0,037  Respiratory analeptic
0,422  0,019  Antihypoxic
0,431  0,032  Lipoprotein disorders treatment
0,396  0,004  Contraceptive female
0,391  0,003  Transcription factor NF kappa B stimulant
0,391  0,009  Lipocortins synthesis antagonist
0,431  0,053  CYP2C9 substrate
0,385  0,009  Protein kinase stimulant
0,380  0,004  3C-like protease (Human coronavirus) inhibitor
0,397  0,024  Antineoplastic (renal cancer)
0,378  0,008  Antiviral (Hepatitis C)
0,407  0,040  CYP2C19 substrate
0,409  0,043  Teratogen
0,366  0,006  Cholesterol synthesis inhibitor
0,389  0,029  Tumour necrosis factor alpha release inhibitor
0,367  0,014  Melanin inhibitor
0,366  0,015  Prostatic (benign) hyperplasia treatment
0,392  0,048  Antifungal
0,371  0,029  Antineoplastic (liver cancer)
0,375  0,051  5 Hydroxytryptamine release stimulant
0,370  0,046  Embryotoxic
0,332  0,017  Antipruritic, non-allergic
0,328  0,017  Gastrin inhibitor
0,367  0,059  Antithrombotic
0,342  0,037  Myocardial infarction treatment
0,351  0,051  Analeptic
0,336  0,037  Vasodilator
0,306  0,008  Expectorant
0,309  0,017  Monophenol monooxygenase inhibitor
0,303  0,016  Liver fibrosis treatment
0,306  0,020  Skin whitener
0,322  0,036  Antiulcerative
0,283  0,006  Choleretic
0,283  0,007  UGT2B10 substrate
0,303  0,029  Antihypotensive
0,275  0,005  Vanilloid agonist
0,356  0,086  Atherosclerosis treatment
0,317  0,050  Renal disease treatment
0,308  0,041  DNA synthesis inhibitor
0,266  0,002  Glycine receptor antagonist
0,285  0,022  Antihelmintic (Nematodes)
0,323  0,061  Cardioprotectant
0,316  0,063  Interleukin 2 agonist
0,260  0,008  Antiinfertility, female
0,255  0,004  5-Alpha-reductase inhibitor
0,312  0,062  Antineoplastic (osteosarcoma)
0,264  0,024  UGT2B15 substrate
0,244  0,007  Arachidonic acid antagonist
0,259  0,029  Antineoplastic (squamous cell carcinoma)
0,284  0,054  Hypolipemic
0,240  0,011  Microtubule formation inhibitor
0,287  0,060  Transcription factor STAT3 inhibitor
0,282  0,058  Cardiovascular analeptic
0,227  0,006  Inducible nitric-oxide synthase inhibitor
0,232  0,012  Alcohol dehydrogenase substrate
0,249  0,031  Diuretic
0,234  0,021  Antifungal enhancer
0,273  0,061  5 Hydroxytryptamine uptake stimulant
0,222  0,013  Cyclooxygenase 3 inhibitor
0,213  0,008  Actinic keratosis treatment
0,238  0,033  Antineoplastic (gastric cancer)
0,209  0,005  Antiviral (Coronavirus)
0,209  0,005  Antiviral (SARS coronavirus)
0,193  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,198  0,011  TRPA1 agonist
0,189  0,003  Na+ K+ transporting ATPase inhibitor
0,187  0,005  UGT2B11 substrate
0,208  0,032  Antidiarrheal
0,181  0,007  Anabolic
0,244  0,071  Free radical scavenger
0,241  0,073  Antiglaucomic
0,291  0,123  Antiobesity
0,192  0,024  Farnesoid X receptor antagonist
0,192  0,031  DNA polymerase I inhibitor
0,184  0,023  Adenylate cyclase stimulant
0,232  0,076  Cardiodepressant
0,169  0,012  Antiprotozoal (Toxoplasma)
0,220  0,068  Antialcoholic
0,173  0,021  UGT2B1 substrate
0,242  0,090  Amyotrophic lateral sclerosis treatment
0,200  0,051  UGT1A3 substrate
0,223  0,076  UGT1A6 substrate
0,307  0,161  Alzheimer's disease treatment
0,149  0,004  Diacylglycerol O-acyltransferase inhibitor
0,152  0,007  Bile acid receptor antagonist
0,189  0,046  Lipid peroxidase inhibitor
0,146  0,003  Heme oxygenase stimulant
0,203  0,062  P-glycoprotein inhibitor
0,206  0,068  Wound healing agent
0,262  0,124  CYP3A4 substrate
0,169  0,035  Topoisomerase I inhibitor
0,205  0,072  Neurotrophic factor enhancer
0,155  0,022  Beta glucuronidase inhibitor
0,264  0,133  Stroke treatment
0,177  0,046  Antinephritic
0,136  0,008  Anticholelithogenic
0,156  0,028  Antiviral (CMV)
0,134  0,006  Aldosterone antagonist
0,133  0,007  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,156  0,030  Antineoplastic antibiotic
0,156  0,032  Vanilloid 1 agonist
0,198  0,076  Anesthetic general
0,156  0,037  Growth stimulant
0,156  0,042  Antihemorrhagic
0,120  0,006  Botulinum neurotoxin type A inhibitor
0,126  0,017  3C-Like protease (SARS coronavirus) inhibitor
0,196  0,091  Fibrosis treatment
0,110  0,005  RNA-directed RNA polymerase stimulant
0,128  0,024  Lanosterol 14 alpha demethylase inhibitor
0,239  0,136  Vasodilator, peripheral
0,178  0,075  Diabetic nephropathy treatment
0,111  0,011  Androgen agonist
0,122  0,026  Antiviral (Rhinovirus)
0,142  0,046  Interleukin 1b antagonist
0,099  0,005  Cholesterol esterase inhibitor
0,110  0,016  Glycine receptor agonist
0,132  0,041  HDL-cholesterol increasing
0,130  0,040  Anticataract
0,130  0,040  Protease inhibitor
0,198  0,109  Antidiabetic symptomatic
0,119  0,032  Antispirochetal
0,195  0,110  Antineoplastic (non-small cell lung cancer)
0,119  0,036  Posttraumatic stress disorder treatment
0,187  0,105  Antineoplastic (lymphoma)
0,202  0,122  Antineoplastic (sarcoma)
0,127  0,047  Aldehyde dehydrogenase substrate
0,086  0,010  Lipocortins synthesis agonist
0,097  0,022  Aromatase inhibitor
0,109  0,034  Topoisomerase II alpha inhibitor
0,124  0,049  Estrogen antagonist
0,079  0,005  Farnesoid X receptor agonist
0,101  0,027  CDC25A inhibitor
0,078  0,005  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,083  0,009  Acetyl-CoA transferase 2 inhibitor
0,105  0,032  Contraceptive male
0,161  0,088  Toxic, respiratory center
0,204  0,132  Transcription factor STAT inhibitor
0,074  0,004  Tubulin agonist
0,097  0,029  Lipase inhibitor
0,128  0,059  Beta amyloid protein antagonist
0,108  0,040  SULT1E1 substrate
0,108  0,041  ABCA1 expression enhancer
0,087  0,020  Postmenopausal disorders treatment
0,106  0,042  Androgen antagonist
0,104  0,040  Ornithine decarboxylase inhibitor
0,170  0,107  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,070  0,007  Microtubule stabilization
0,106  0,044  Antineoplastic alkaloid
0,119  0,057  Endometrios treatment
0,082  0,022  SULT2A1 substrate
0,075  0,017  Postcoital contraceptive
0,071  0,014  Anesthetic inhalation
0,194  0,137  UGT1A9 substrate
0,160  0,105  Antirickettsial
0,091  0,037  Keratolytic
0,058  0,006  Estrone sulfatase inhibitor
0,185  0,133  Spasmolytic
0,058  0,008  Glucose-6-phosphate dehydrogenase inhibitor
0,075  0,027  Nitric oxide donor
0,126  0,077  Anesthetic
0,143  0,096  Muscle relaxant
0,072  0,025  Estrogen agonist
0,052  0,006  Cholesterol ester transfer protein antagonist
0,074  0,029  Interferon inducer
0,134  0,093  Phospholipase A2 inhibitor
0,048  0,012  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,069  0,034  Prostaglandin F2 alpha antagonist
0,038  0,005  Vanilloid 2 agonist
0,052  0,019  Parathyroid hormone antagonist
0,110  0,078  Shock treatment
0,082  0,049  Interferon agonist
0,079  0,047  Antibiotic
0,159  0,127  Antiparkinsonian, rigidity relieving
0,048  0,017  Kainate receptor agonist
0,107  0,078  Proteasome inhibitor
0,117  0,088  Bone formation stimulant
0,045  0,016  Cholesterol absorption inhibitor
0,102  0,074  Mucolytic
0,137  0,110  Interleukin 6 antagonist
0,026  0,004  Telomerase stimulant
0,030  0,009  5-Alpha-reductase 2 inhibitor
0,087  0,067  Paget's disease treatment
0,037  0,018  Melatonin 2 agonist
0,080  0,061  Ca(v)3.1 blocker
0,050  0,032  Antiviral (Herpesvirus 3, Human)
0,027  0,009  Corticosteroid-like
0,030  0,012  Retinoid X gamma receptor antagonist
0,062  0,043  Antimycoplasmal
0,028  0,011  Retinoid X gamma receptor agonist
0,053  0,036  Acetyl-CoA transferase inhibitor
0,041  0,024  Retinoic acid alpha receptor agonist
0,029  0,014  Hedgehog signaling activator
0,183  0,167  Antipsoriatic
0,025  0,010  Retinoic acid gamma receptor agonist
0,064  0,051  Hypercalcemia treatment
0,024  0,011  Vitamin D receptor antagonist
0,023  0,012  Retinoid X beta receptor agonist
0,137  0,128  Psychostimulant
0,024  0,015  Retinoic acid receptor agonist
0,035  0,025  Retinoid X receptor agonist
0,018  0,009  Vitamin D receptor agonist
0,097  0,089  Topoisomerase II inhibitor
0,123  0,116  Growth hormone agonist
0,065  0,058  Andropause treatment
0,031  0,026  Estrogen receptor alpha agonist
0,090  0,084  Estrogen receptor beta antagonist
0,066  0,060  Histone deacetylase SIRT1 stimulant
0,066  0,060  Histone deacetylase stimulant
0,071  0,066  Narcotic antagonist
0,016  0,012  5-Alpha-reductase 1 inhibitor
0,019  0,015  Retinoic acid beta receptor agonist
0,012  0,009  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,120  0,118  CC chemokine 6 receptor antagonist
0,015  0,014  Progesterone agonist
0,031  0,030  HMG CoA reductase inhibitor

